Constant restructuring of NHS is demoralising staff, survey finds

The number of NHS reorganisations in recent years is a key reason for the health service’s struggle to retain staff, a poll has found.

The NHS has been struggling to meet rising demand with a chronic shortage of staff and the results of a survey, published on Friday, suggest that a feeling of constant upheaval is at least partially to blame.

The poll by Wilmington Healthcare UK of more than 2,000 nurses, GPs and hospital doctors across the UK found that 64% blamed staff retention problems on the continuous and “demoralising” national changes in NHS workforce planning that had occurred since 2000.

The concerns about the state of flux are revealed as as the health service faces further big upheaval, in the shape of the controversial sustainability and transformation plans (STPs), which are intended to improve productivity and efficiency and so plug the NHS funding gap. The STPs will mean some hospitals and beds lost and more services being delivered in the community.

Wilmington Healthcare’s managing director, Gareth Thomas, said: “Our survey shows that continued changes in workforce planning since 2000 have been a major factor in NHS staff retention problems.

“This is of particular concern as the planned introduction of STPs in April 2017 is set to bring the biggest shake-up to NHS services since the publication of the Five Year Forward View.

“As the NHS moves towards a truly devolved health and social care system, it is clear that urgent action must be taken to support staff and help them manage the huge changes that are envisaged.”

Changes in NHS workforce planning, due to organisational changes, and said to have affected staff retention, included the establishment of primary care trusts, workforce development confederations and strategic health authorities, all since abolished (within three years of their creation in the case of WDCs). Primary care trusts were replaced by clinical commissioning groups.

Other key factors cited by respondents as adversely affecting the NHS’s ability to retain staff were low morale (92% of respondents) and poor pay and rewards (72%).

With concerns raised that the UK’s exit from the EU would exacerbate the shortage of NHS staff – 59,000 NHS staff are nationals of other EU countries – the survey also asked respondents about the impact of Brexit. Just under half (48%) said it would bemore difficult to recruit and retain staff, 45% said it would make no difference and 7% said it would be easier to recruit and retain staff. According to the Nuffield Trust, 10% of doctors and 4% of nurses are from the EU.

More than eight in 10 respondents (85%) said access to training and development was the key requirement of the future NHS workforce, closely followed by flexible working and career progression (both 78%).

An NHS England spokeswoman said: “This poll is wide of the mark and at odds with our own thorough and robust staff survey which garnered 423,000 responses. It found 80% of frontline NHS staff say they are able to do their job to a standard they are personally pleased with, 90% of staff say their job makes a difference for patients, and 92% of staff feel trusted to do their jobs, which does not seem to suggest a low morale workforce.”

Constant restructuring of NHS is demoralising staff, survey finds

A lot more NHS cash – yes, but no restructuring | @guardianletters

The government need to listen to David Nicholson’s stark warnings that the NHS are not able to survive if it is denied “extra money”, but one more best-down reorganisation is not the answer (NHS informed to commit billions on reform or face oblivion, 13 March). It are not able to sustain services offered the combined pressure of increasing patient demand and falling assets. Modify that puts medical professionals and sufferers at the heart of decision generating is required, but centralising hospital services would be an needless restructure that would harm the versatility to react to the wants of local communities.

The government need to guarantee that clinical needs come initial, NHS providers reflect the neighborhood needs of sufferers and, as Nicholson says, our health service have to have the sources to deliver these solutions. Patients have to get the greatest achievable care – which centralisation and budget cuts will not offer.
Dr Mark Porter
Chair, British Health-related Association

• David Nicholson and others who keep banging the drum for a substantial reduction in the quantity of hospitals to offer money for care closer to patients’ properties are currently being disingenuous. It really is not just a question of bricks and mortar, as Nicholson asserts hospital closures usually indicate enormous bed reductions, yet even now we have far fewer hospital beds in proportion to population than the OECD average – half as many as France, for example. How can cutting them more be a secure and sustainable approach with a expanding and ageing population?

It can not be a query of 1 or the other. As Dr Saleyha Ahsan mentioned in her riveting piece primarily based on direct encounter (On the NHS front line there is no swift cure for the crisis, five March), enhanced care in the community is crucial “but if a lot more acute beds shut, the A&ampE waits will get longer for sick individuals requiring admission”.
Professor Ron Glatter
Hemel Hempstead, Hertfordshire

• It really is a small late for the outgoing chief executive to say the NHS demands a multi-billion pound change fund to rationalise hospital solutions. But his fundamental stage, that we need to invest in local community companies and assets prior to dismantling hospitals, is sound. Otherwise the public will never ever feel it is something other than expense cutting. And it is why there isn’t much to demonstrate yet for shifting care out of hospitals it just is not achievable to close providers at the same time as opening new ones.

It is interesting that he is utilizing the identical language of the mental hospital closures 30 many years ago. Thirty many years on we will be hunting back in astonishment at the way we employed to care for the frail and elderly in the final months of their lives, in institutions that are created for healthcare therapy rather than the care and compassion we largely require. This is essential. We have completed it prior to in even less promising situations – with the added stigma of psychological sickness – by creating a huge programme of alter and institutional closures. Nicholson’s message aligns fully with our manifesto for primary care, which launched exactly a single yr in the past. Our message to the incoming NHS chief executive is easy. Please just do it: launch the adjust fund.
Rick Stern
Chief executive, NHS Alliance

• The interview illustrates Nicholson’s isolation from actuality. To instance the provision of care in the neighborhood following the closure of extended remain psychiatric hospitals in the 1980s as a accomplishment is exceptional. He should read Care in the Community Myth or Actuality, a review that paperwork the experiences of 750 former sufferers of Friern Barnet hospital. Briefly, many showed some progress in their initial year, followed by a continuing decline in subsequent many years, since of the lack of proper investment in local community mental health services. This predicament continues and accelerates right now, with the closure of psychiatric beds, closure of rehabilitation solutions and below-provision of appropriate supported housing. Support is often presented by low-paid, unqualified employees.

The puzzling announcements by government of equality of provision for mental wellness with physical well being at the very same time as announcing cuts to an currently inadequate mental health budget is deeply troubling. We require to be profoundly concerned.
John Holmes
London

• The Nationwide Overall health Action Party has place forward plans to increase value for cash in the NHS based mostly on disregarded operate completed in the course of the final parliament:

Guarantee that all remedy is based on proof of effectiveness and ideal worth. Abolish the pricey industry in healthcare and the purchaser/supplier split. GPs and hospitals could then operate closely with each other to make certain that only people who are not able to be cared for by enhanced local community providers want admission to hospital. Patients with minor and lengthy-phrase illnesses need to be taught to care for themselves much more independently. Tackle weight problems, smoking and extreme alcohol intake far more efficiently.

Of course Sir David Nicholson is appropriate: money would have to be invested on strengthening local community care prior to these cost savings could be made. The outcome could conserve the NHS as a publicly provided and funded services for future generations.
Richard Taylor
Co-leader, Nationwide Health Action Celebration

• Yes, we want to be confident that acute companies are obtainable in sensible locations. Even so, the sole criterion need to not be based purely on population. It is also simple for a Londoncentric NHS to style companies this way utilizing minimum population as 1 of the major criteria is taking a sledge hammer to crack a nut. Get vascular surgical treatment. Rurality, transport and street entry, age demographics and deprivation must all be calculated when we determine where we supply our acute centres. With out this we will merely be condemning these who are elderly and residing in rural areas to a even more dimunution of services.
Rik Evans
Truro, Cornwall

A lot more NHS cash – yes, but no restructuring | @guardianletters

NHS sufferers "face much more remedy rationing considering that coalition restructuring"

GPs have said sufferers are encountering developing problems in acquiring care from community nurses, counselling, cataract surgery and fertility treatment Photograph: Dominic Lipinski/PA

Sufferers are dealing with developing rationing of remedies such as counselling, cataract removal and IVF since the coalition restructured the NHS final yr, GPs say.

In a survey of 315 family members medical doctors, GP magazine identified that 71% believed that restrictions on access to therapy in their area had elevated considering that April 2013, when the controversial shake-up of the NHS in England began.

That led to the creation of 211 GP-led clinical commissioning groups (CCGs), which control the spending budget for healthcare in an region and make a decision who can obtain what treatment. GPs mentioned sufferers have been encountering expanding issues in acquiring care from neighborhood nurses, counselling, cataract surgical procedure and fertility remedy. Rationing has improved drastically in the past nine months, medical professionals responding to the survey explained.

One particular loved ones physician, a spouse in a surgery, informed the magazine: “We have enormous expense pressures and this is resulting in increased rationing and fragmentation of solutions to reduce charges.”

Nevertheless, entry to excess weight-loss surgical treatment has enhanced, though sufferers can encounter what Dr David Haslam, a GP and chair of the National Weight problems Forum, called a “torturous” path to obtaining it. And some obese sufferers are expected to attend fat-loss programmes for at least a yr prior to they will be regarded as for surgical treatment.

Some CCGs aim to scrap rationing policies inherited from their predecessor major care trusts as soon as their finances are in the black. For illustration, six which have previously refused to offer you women IVF treatment method as suggested by the National Institute of Well being and Care Excellence hope to commence undertaking so.

Dr Richard Vautrey, deputy chairman of the British Health-related Association’s GPs committee, said that “many GPs are concerned about reduced engagement with community nursing teams and reduced or delayed accessibility to psychological companies, which is obtaining an affect on patient care.”

Andy Burnham, the shadow overall health secretary, said: “Labour has consistently warned that David Cameron’s re-organisation would consequence in a postcode lottery running riot via the NHS and this survey confirms that is exactly what is happening.”

A spokeswoman for NHS England denied patients were dealing with delays. “Well being support budgets have been protected and NHS England, by way of its mandate [from the Department of Well being], is guaranteeing that individuals acquire the companies they require in a timely manner”, she stated.

NHS sufferers "face much more remedy rationing considering that coalition restructuring"

Four Motives Merck"s R&D Restructuring May Not Save The Drug Giant (Or The Sector)

Last Friday, Wall Street Journal reporters Peter Loftus and Jonathan Rockoff broke the story that Merck Merck is organizing a dramatic R&ampD restructuring.  The purpose is to look externally for far more programs, rather than to count on Merck’s legendary research labs to provide the bulk of the pipeline.  Four “innovation hubs” will be developed, based near Boston, San Francisco, London, and Shanghai.

As Fierce Biotech’s John Carroll pointed out Saturday, this approach, while probably innovative for Merck, is extremely considerably in line with the course the sector has been taking.

Even inside Merck, this move might be far more evolutionary than revolutionary, given their current – and usually productive – efforts to significantly boost their organization development and licensing (BD&ampL) abilities and status, scoring persistently higher on BCG’s annual partnering survey, for instance, following a deliberate push in that course.

The factors for the industry shift are clear: pharma businesses are struggling to build new items, and inner labs aren’t cutting it.  Unanswered, nonetheless, is regardless of whether the shift from R&ampD to S&ampD (i.e. less research, far more search) will be better, or just various.

The root question is really why pharmas struggle to come up with new merchandise – why is not pharma as innovative as it requirements to be?

The effortless reply would be that large pharma has grow to be too bulky, too bureaucratic, insufficiently nimble – it cannot end stumbling over itself.

Despite the fact that these descriptors are largely accurate, they may also not talk to the underlying supply of the issue: inadequate understanding of the underlying biology.

As sensible as we believe we are, and as significantly as we feel we’ve discovered, we truly really don’t recognize the fundamental basis of most serious illnesses – and even in cases the place there’s a discrete underlying lead to we can recognize, human physiology is so unbelievably difficult that successfully focusing on the problem can be prohibitively tough, at least with our present comprehending.

Really do not take my word for it – here’s what Merck’s new head of R&ampD, Roger Perlmutter, told my Forbes colleague Matt Herper in September:

“…if we’re discovering medication, the dilemma is that we just really don’t know ample. We genuinely understand extremely minor about human physiology. We don’t know how the machine functions, so it’s not a shock that when it is broken, we really don’t know how to repair it. The reality that we ever make a drug that gives favorable effects is a bloody miracle because it’s really challenging to realize what went incorrect.”

The stage is not that we shouldn’t try – without a doubt, it is the obligation of every person in biomedicine to marshal the extremely very best information we have in effort to supply the greatest achievable therapy to sufferers presently sick – but rather that these attempts are typically associated with intrinsically minimal probabilities of good results, provided how a lot we just really don’t realize.

Pharma firms shifting towards externally-sourced plans would be valuable if there are wonderful ideas out there that large businesses are missing, or that are not being adequately acknowledged due to inner politics – the renowned “not invented here” issue that has traditionally plagued Merck, as well as most other big businesses.

It is also feasible that externally-sourced applications will be easier to assess objectively and terminate in a timely fashion this could be a important benefit, given the industry’s struggle with this precise challenge.

At the exact same time, sourcing plans externally is unlikely to be a panacea.

1st – and most importantly — there basically could not be sufficient wonderful concepts out there, ideas that meet Merck’s criteria of top to merchandise “that offer unambiguous promotable advantage.”

Second, you might not know – it may well not even be achievable to recognize – a promising product early on.  Slews of medication that proved very impactful have been not acknowledged as useful early in their development cancer drugs Imbruvica (ibrutinib) and Velcade  (bortezomib) come right away to mind.  Conversely, numerous merchandise that appeared like blockbusters crashed and burned, highlighting the challenge (several, such as me, would say utter futility) of predicting commercial overall performance early in the game.  As I’ve long argued and not too long ago highlighted (in the context of this essential publish by David Grainger of Index Ventures), this would recommend a solution (at least for early goods) informed by a deep sense of humility, a preference for empiricism, and an approach that enables several rapid, low-cost shots – successfully the opposite of the “pick the winners” strategy.

Third, it’s straightforward to idealize what you really do not genuinely know.  This is the flip side of the “not invented here” reflex – the concept that external plans may possibly hold the answers to your hopes and dreams.  When you develop a plan internally, you have a tendency to know it very well, warts and all.  It’s always more difficult to recognize external packages as deeply, and they typically come with liabilities it can be challenging to understand or enjoy, even after responsible diligence.  This is true not only in-licensed applications, but also (especially) for early scientific concepts emerging from academic labs it turns out that a lot of the most promising university data – frequently (specially!) that published in the leading journals – does not appear to be robust or reproducible.  Pressure-testing academic theories remains an crucial, expensive, and profoundly undervalued industry action.

Fourth, a particular dilemma connected with BD&ampL in common is the separation of transaction and development – the people who go out and do the discounts are not typically the folks who will commit their days working on the actual program, leading to a significant agency difficulty.   As I’ve mentioned, I’d desire an approach in which the people doing the seeking are also the ones who will be functioning total-time on the plan they deliver in, and thus have far much more skin in the game.

Four Motives Merck"s R&D Restructuring May Not Save The Drug Giant (Or The Sector)